Rong-Kun Chang

This inventor holds 24 USPTO granted patents and 5 published patent applications, plus 9 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Supernus Pharmaceuticals, Inc., Shire Laboratories, Inc., Shire LLC, USA. Active years: 2001-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rong-Kun Chang. Retrieved from https://idiyas.com/inventor/rong-kun-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 5)

% Patents Active = 58.3

CIPO Patents = 9

EPO Patents = 10 (Patent Applications = 5)

Average Co-Inventor Count = 2.9

ph-index = 11

Forward Citations = 1,071(Granted Patents)

Location History:

Hockessin, DE (US) (2001 - 2003)
Rockville, MD (US) (2001 - 2021)

Company Filing History:

15 out of 83

Supernus Pharmaceuticals, Inc.

patents

8 out of 25

Shire Laboratories, Inc.

Years Active: 2001-2021

Loading Chart...

Areas of Expertise:

CNS Compounds

Drug Formulations

Abuse Potential

Enteric Materials

Therapeutics

Tetracyclines

Pulsed Dose Delivery

Sustained Release

Pharmaceutical Compositions

Bioavailability Enhancers

Crystalline Cyclodextrins

Dissolution Profiles

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11077114 - Stabilized formulations of CNS compounds (2021-08-03),

2. 10149853 - Stabilized formulations of CNS compounds (2018-12-11),

3. 9308176 - Less abusable pharmaceutical preparations (2016-04-12),

4. 9144551 - Drug formulations having reduced abuse potential (2015-09-29),

5. 8906413 - Drug formulations having reduced abuse potential (2014-12-09),

6. 8808714 - Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics (2014-08-19),

7. 8748472 - Stabilized formulations of CNS compounds (2014-06-10),

8. 8709478 - Once daily formulations of tetracyclines (2014-04-29),

9. 8470364 - Once daily formulations of tetracyclines (2013-06-25),

10. 8394406 - Once daily formulations of tetracyclines (2013-03-12),

11. 8394405 - Once daily formulations of tetracyclines (2013-03-12),

12. 8206740 - Once daily formulations of tetracyclines (2012-06-26),

13. 7910128 - Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics (2011-03-22),

14. RE42096 - Oral pulsed dose drug delivery system (2011-01-31),

15. 7749532 - Once daily formulations of tetracyclines (2010-07-06),

Title: The Innovative Journey of Rong-Kun Chang

Introduction: Rong-Kun Chang, a pioneering inventor based in Rockville, MD (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Rong-Kun Chang's latest patents showcase his commitment to innovation, with a focus on cutting-edge technologies in the areas of artificial intelligence, renewable energy, and biotechnology.

Career Highlights: Throughout his illustrious career, Rong-Kun Chang has been at the forefront of technological advancements, leading research and development teams to create solutions that have revolutionized industries worldwide.

Collaborations: Rong-Kun Chang has collaborated with leading universities, research institutions, and multinational companies to bring his inventions to life, fostering a culture of innovation and excellence in every project he undertakes.

Conclusion: Rong-Kun Chang's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, solidifies his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.